home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
REVOLUTION Medicines Raises $56 Million in Series B Financing
REVOLUTION Medicines Raises $56 Million in Series B Financing
Post navigation
Previous Post
Previous
Blueprint Medicines Announces Proof-of-Concept Data for Highly Selective RET Inhibitor BLU-667 from Phase 1 ARROW Clinical Trial in Patients with RET-Altered Solid Tumors
Next Post
Next
Blueprint Medicines to Report First Quarter 2018 Financial Results on Wednesday, May 2, 2018